Privacy-preserving medical AI leaves healthcare organizations with a difficult operating question: which institution should contribute to the next training cycle? New research on participant selection makes that question harder to treat as routine scheduling. For teams developing diagnostic systems
Decision-curve analysis suggests that multiparametric MRI fusion models provide a higher clinical net benefit than current standard-of-care preoperative staging methods. In 2026, the landscape of gynecological oncology continues to evolve away from a one-size-fits-all surgical approach, moving
The silent progression of liver-induced cognitive decline has historically lacked a precise neuroimaging signature that accounts for both physiological structure and active neuronal firing. The application of regional homogeneity and amplitude of low-frequency fluctuation ratios has uncovered
Triple-negative breast cancer remains a significant therapeutic challenge due to its aggressive nature and the absence of common hormonal receptors. Because patients lack estrogen, progesterone, and HER2 receptors, standard endocrine therapies and HER2-targeted treatments are ineffective, leaving
Blocking the movement of misfolded alpha-synuclein through the cerebrospinal fluid could potentially quarantine pathology and slow the progression of MSA. This perspective represents a fundamental shift in how the medical community approaches neurodegenerative disorders in 2026. Multiple System
Future efforts will focus on scaling the model across multiple institutions to enhance its predictive robustness and clinical utility in various settings. Imagine a patient undergoing a routine CT scan for an injury, while an invisible digital eye simultaneously identifies signs of chronic kidney
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
